A Multi-centre Study of Shoe-worn Insoles and Knee Osteoarthritis (MULTIWEDGE)

March 24, 2025 updated by: Michael Hunt, University of British Columbia

A Multi-centre Feasibility Study Assessing Shoe-worn Insoles to Improve Clinical and Biomechanical Features of Knee Osteoarthritis

Shoe-worn insoles (also known as orthotics) can provide symptomatic relief for people with knee osteoarthritis. However, given they act at the feet, and given that many people with knee osteoarthritis also report foot pain, it is important to assess the effects of these devices at both joints. We will conduct a multi-centre randomized pilot trial to determine feasibility and preliminary efficacy.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5R 3N9
        • Recruiting
        • Motion Analysis and Biofeedback Laboratory
        • Contact:
          • Natasha Krowchuk
          • Phone Number: 6048227948

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • medial tibiofemoral OA defined as definitive osteophytes and joint space narrowing in the medial compartment, as confirmed with radiographs
  • history of knee pain longer than 6 months
  • average self-reported knee pain of at least 3 out of 10 (using an 11-point numerical rating scale with terminal descriptors of 0 = "no pain" and 10 = "worst pain imaginable") over the 6 months prior to baseline testing
  • pain in the same foot/feet as the painful knee(s)
  • ability to communicate in English
  • show an immediate biomechanical response to the insoles. This final eligibility criterion will be determined from an in-person biomechanical assessment after participants have passed all previous eligibility screening.

Exclusion Criteria:

  • radiographic evidence of more lateral tibiofemoral OA than medial
  • knee surgery or intra-articular injection within the previous 6 months
  • current or recent (within 6 months) corticosteroid use for any reason
  • presence of a systemic arthritic condition
  • history of knee joint replacement or tibial osteotomy
  • any other condition affecting lower limb function
  • current usage of shoe-worn insoles, or planning to acquire footwear modifications in the next 6 months
  • any previous experience with insoles that resulted in increased lower limb pain or a self- or clinician-initiated termination of use.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lateral wedge insoles (LWIs)
The LWIs will incorporate a 6 degree wedge along the lateral edge of the insole.
Participants will be asked to wear these insoles in their own shoes for at least 5 hours per day for a period of 3 months. The LWIs will be constructed via 3D printing using a material of uniform density made to the length of the participant's feet, and will incorporate a 6 degree wedge along the lateral edge.
Experimental: Lateral wedge plus custom arch support (LWAS)
The LWAS insoles will incorporate custom arch support along the medial edge as well as a 6 degree wedge along the lateral edge of the insole.
Participants will be asked to wear these insoles in their own shoes for at least 5 hours per day for a period of 3 months. These insoles will be designed based on an innovative tablet-based app designed by industry partner Kintec Footlabs, who will be the provider of the insoles for this project. Using the high-fidelity 3D scanning tool available (Apple's True Depth sensor), the Epitek Self-Scanner app captures tens of thousands of 3D data points within a single 1-second capture, and then uploads this foot data to a secure patient record system that is used for insole fabrication. The LWAS insoles will be comprised of variable density material (more dense laterally than medially) and milled directly to produce a full-length shell. The 6 degree wedge will be incorporated along the full lateral length of the insoles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment - number of screened patients who are eligible
Time Frame: from onset of recruitment through study completion
The number of screened patients determined eligible to be enrolled in the study.
from onset of recruitment through study completion
Retention - proportion of assessments with complete outcome measures data
Time Frame: immediately after the intervention
Proportion of assessments with complete outcome measures data out of total number of assessments in the study protocol.
immediately after the intervention
Insoles Delivery
Time Frame: from date of insoles ordering until date of delivery to the laboratory, assessed up to 3 months
Time between foot scan assessment and delivery of insoles. Given that insoles will be manufactured centrally and distributed to the sites, we are interested in assessing the expected timeframe for enrollment in the study.
from date of insoles ordering until date of delivery to the laboratory, assessed up to 3 months
Self-reported knee pain
Time Frame: Baseline, 3 Months
Knee pain will be measured by the Pain subscale (9 items) of the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and at 3-months. Each item is rated on a 5 points Likert scale where 0 = "No problems" and 4 = "Extreme Problems". Higher scores indicate better function. The scores are normalized to 0-100%.
Baseline, 3 Months
Self-reported foot pain
Time Frame: Baseline, 3 Months
Foot pain will be measured at baseline and at 3-months by the Pain subscale (7 items) of the Foot Function Index revised short form (FFI-RS). This is a self-report questionnaire consisting of 34 items that provides the ability to quantify aspects of foot pain, disability and activity limitation.
Baseline, 3 Months
External knee adduction moment impulse
Time Frame: Baseline, 3 Months
The external knee adduction moment impulse will be calculated. Participants will walk on an instrumented walkway (embedded force platform(s)) while high speed cameras track the trajectories of markers placed on bony landmarks. Moments will be calculated using an inverse dynamics approach.
Baseline, 3 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported overall physical function
Time Frame: Baseline, 3 Months
Physical function will be measured by the Function, Daily Living subscale (17 items) of the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and at 3-months. Each item is rated on a 5 points Likert scale where 0 = "No problems" and 4 = "Extreme Problems". Higher scores indicate better function. The scores are normalized to 0-100%.
Baseline, 3 Months
Self-reported foot function
Time Frame: Baseline, 3 Months
Foot function will be measured at baseline and at 3-months by the Activity Limitations subscale (3 items) of the Foot Function Index revised short form (FFI-RS). This is a self-report questionnaire consisting of 34 items that provides the ability to quantify aspects of foot pain, disability and activity limitation.
Baseline, 3 Months
External knee flexion moment impulse
Time Frame: Baseline, 3 Months
The external knee flexion moment impulse will be calculated using the same methods as described for the external knee adduction moment impulse.
Baseline, 3 Months
Self-selected gait speed
Time Frame: Baseline, 3 Months
Self-selected gait speed will be calculated during the biomechanical gait analyses.
Baseline, 3 Months
Rearfoot eversion peak
Time Frame: Baseline, 3 Months
Participants will walk on an instrumented walkway while high speed cameras track the trajectories of markers placed on bony landmarks.
Baseline, 3 Months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exit Interview
Time Frame: 3 months
Participants will be invited to take part in semi-structured interviews, and asked about their knee and pain, their experiences with their insoles, and their attitudes towards different treatment approaches to manage knee OA. The purpose of this exploratory component will be to identify any themes related to the approach and design of the study that would need to be modified for the definitive RCT. Semi-structured interviews will be conducted to explore participants' attitudes and feelings about the interventions and the study design. The conversations will be recorded digitally, transcribed verbatim, and analyzed using a framework analysis. Themes will be developed, discussed, adjusted, and grouped in an iterative and inductive process. All data will be coded according to the final thematic index generated.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

January 23, 2024

First Submitted That Met QC Criteria

February 1, 2024

First Posted (Actual)

February 9, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Lateral wedge insoles (LWIs)

Subscribe